Jump to content
RemedySpot.com

Antibody response following hepatitis B vaccination in dialysis patients: Does depression and life quality matter?

Rate this topic

Guest guest

By Guest guest
in Health, Medicine and Natural Healing 09

 Share

Recommended Posts

Guest guest

Guest guest

Posted
Posted

Vaccine. 2009 Aug 1. [Epub ahead of print]

Antibody response following hepatitis B vaccination in dialysis patients: Does

depression and life quality matter?

Afsar B, Elsurer R, Eyileten T, Yilmaz MI, Caglar K.

Gülhane School of Medicine, Department of Nephrology, Ankara, Turkey.

Previously, it was demonstrated that antibody production against hepatitis B

virus (HBV) surface antigen (anti-HBs) achieved in hemodialysis patients is

suboptimal. Decreased health-related quality of life (HRQOL) and depression is

common among hemodialysis patients. This study evaluated whether HRQOL and

depressive behavior are associated with antibody response against HBV surface

antigen in hemodialysis patients. Depressive symptoms and HRQOL were assessed by

Beck Depression Inventory (BDI) and Medical Outcomes Study Short Form (SF-36),

respectively. Patients were separated into non-seroconversion (anti-HBs antibody

titers /=10IU/L) groups. Among 188 patients, 37 (19.7%) were diagnosed as

nonresponsive to vaccination (anti-HBs antibody titers

Link to comment
Share on other sites
Guest guest

Guest guest

Posted
Posted

Vaccine. 2009 Aug 1. [Epub ahead of print]

Antibody response following hepatitis B vaccination in dialysis patients: Does

depression and life quality matter?

Afsar B, Elsurer R, Eyileten T, Yilmaz MI, Caglar K.

Gülhane School of Medicine, Department of Nephrology, Ankara, Turkey.

Previously, it was demonstrated that antibody production against hepatitis B

virus (HBV) surface antigen (anti-HBs) achieved in hemodialysis patients is

suboptimal. Decreased health-related quality of life (HRQOL) and depression is

common among hemodialysis patients. This study evaluated whether HRQOL and

depressive behavior are associated with antibody response against HBV surface

antigen in hemodialysis patients. Depressive symptoms and HRQOL were assessed by

Beck Depression Inventory (BDI) and Medical Outcomes Study Short Form (SF-36),

respectively. Patients were separated into non-seroconversion (anti-HBs antibody

titers /=10IU/L) groups. Among 188 patients, 37 (19.7%) were diagnosed as

nonresponsive to vaccination (anti-HBs antibody titers

Link to comment
Share on other sites
Guest guest

Guest guest

Posted
Posted

Vaccine. 2009 Aug 1. [Epub ahead of print]

Antibody response following hepatitis B vaccination in dialysis patients: Does

depression and life quality matter?

Afsar B, Elsurer R, Eyileten T, Yilmaz MI, Caglar K.

Gülhane School of Medicine, Department of Nephrology, Ankara, Turkey.

Previously, it was demonstrated that antibody production against hepatitis B

virus (HBV) surface antigen (anti-HBs) achieved in hemodialysis patients is

suboptimal. Decreased health-related quality of life (HRQOL) and depression is

common among hemodialysis patients. This study evaluated whether HRQOL and

depressive behavior are associated with antibody response against HBV surface

antigen in hemodialysis patients. Depressive symptoms and HRQOL were assessed by

Beck Depression Inventory (BDI) and Medical Outcomes Study Short Form (SF-36),

respectively. Patients were separated into non-seroconversion (anti-HBs antibody

titers /=10IU/L) groups. Among 188 patients, 37 (19.7%) were diagnosed as

nonresponsive to vaccination (anti-HBs antibody titers

Link to comment
Share on other sites
Guest guest

Guest guest

Posted
Posted

Vaccine. 2009 Aug 1. [Epub ahead of print]

Antibody response following hepatitis B vaccination in dialysis patients: Does

depression and life quality matter?

Afsar B, Elsurer R, Eyileten T, Yilmaz MI, Caglar K.

Gülhane School of Medicine, Department of Nephrology, Ankara, Turkey.

Previously, it was demonstrated that antibody production against hepatitis B

virus (HBV) surface antigen (anti-HBs) achieved in hemodialysis patients is

suboptimal. Decreased health-related quality of life (HRQOL) and depression is

common among hemodialysis patients. This study evaluated whether HRQOL and

depressive behavior are associated with antibody response against HBV surface

antigen in hemodialysis patients. Depressive symptoms and HRQOL were assessed by

Beck Depression Inventory (BDI) and Medical Outcomes Study Short Form (SF-36),

respectively. Patients were separated into non-seroconversion (anti-HBs antibody

titers /=10IU/L) groups. Among 188 patients, 37 (19.7%) were diagnosed as

nonresponsive to vaccination (anti-HBs antibody titers

Link to comment
Share on other sites

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
 Share
Go to topic listing
×
×
  • Create New...